RESMED, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 210.6 USD | -0.17% |
|
+2.22% | +22.61% |
ETFs positioned on ResMed, Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.09% | 21 M€ | +7.83% | - | |
| 1.03% | 15 M€ | -4.01% | ||
| 0.73% | 204 M€ | +10.54% | ||
| 0.43% | 7 M€ | +5.53% | ||
| 0.43% | 38 M€ | -.--% | ||
| 0.38% | 9 M€ | -.--% | - | |
| 0.38% | 2 M€ | +9.08% | ||
| 0.33% | 108 M€ | +10.52% | ||
| 0.29% | 5 M€ | -72.95% | - | |
| 0.21% | 55 M€ | +11.57% | ||
| 0.20% | 10 M€ | +10.28% | ||
| 0.20% | 252 M€ | +8.21% | ||
| 0.18% | 219 M€ | +17.17% | - | |
| 0.18% | 1,448 M€ | -.--% | - | |
| 0.18% | 2,334 M€ | +16.55% | ||
| 0.16% | 825 M€ | +11.11% | ||
| 0.16% | 9 M€ | +7.98% | - | |
| 0.16% | 36 M€ | +22.19% | ||
| 0.16% | 4 M€ | -.--% | - | |
| 0.13% | 276 M€ | +11.40% | - | |
| 0.12% | 261 M€ | -.--% | - | |
| 0.12% | 200 M€ | +11.72% | - | |
| 0.12% | 488 M€ | +14.59% | ||
| 0.11% | 8 M€ | +4.93% | - | |
| 0.11% | 31 M€ | +0.05% | - | |
| 0.11% | 20 M€ | +4.92% | - |
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Calendar
2024-07-31
- Q4 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
210.9
USD
Average target price
218.7
USD
Spread / Average Target
+3.70%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +22.61% | 30.98B | |
| +9.48% | 222B | |
| +13.72% | 195B | |
| +23.79% | 148B | |
| +33.39% | 113B | |
| +3.92% | 66.45B | |
| +15.59% | 53.11B | |
| +3.16% | 50.03B | |
| -4.35% | 38.8B | |
| -1.27% | 34.85B |
- Stock Market
- Equities
- RMD Stock
- Funds and ETFs ResMed, Inc.
